ALX Oncology Holdings (ALXO): Volume dodolan mangsa ngarep perusahaan

Logo grafis ALX Oncology Holdings (ALXO)

ALX Oncology Holdings (ALXO) is integrating ESG principles into the development of cancer therapies, ensuring bioethics and environmental sustainability. A team of distinguished biologists possesses the academic freedom necessary to achieve scientific breakthroughs. This future sales volume chart demonstrates business resilience, where 0.00 reflects the latest metric level. Stable demand for biotechnology gives the asset defensive qualities, insulating the company from global macroeconomic volatility.

Prakiraan pendapatan perusahaan: ALX Oncology Holdings (ALXO) kanggo 04.07.2022 - 18.11.2026

ALXO (ALX Oncology): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:ALX Oncology
Sampel barang alxoncology.com

ALX Oncology Holdings (ALXO) focuses on high-tech cancer immunotherapy, leveraging an elite scientific team. This metric assesses the projected cash flow from future commercial realizations, serving as a fundamental filter for business sustainability. The investor utilizes this calculation to minimize risks during the volatility of R&D stages. Analyzing changes in future sales volume on GURU.Markets allows for the identification of hidden capital drawdowns. This chart's dynamics determine the balance between asset protection and growth potential.

Pesaing langsung

Prakiraan pendapatan perusahaan ImmunityBio Inc (IBRX)|Volume dodolan mangsa ngarep perusahaan Immunocore PLC IMCR|Janux Therapeutics Inc - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Arcus Corp RCUS|ZYME - Prakiraan pendapatan perusahaan|TNGX (tangotx.com) - Prakiraan pendapatan perusahaan|Iovance Corp (IOVA) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Immatics Corp (IMTX)|Volume dodolan mangsa ngarep perusahaan XNCR|CMPX - Prakiraan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan REPL (Replimune Corp)|Prakiraan volume pendapatan perusahaan LYEL|Prakiraan volume dodolan IPHA (Innate Pharma)|Pendapatan mangsa ngarep perusahaan PYXS|Compugen Limited - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan IO Biotech Inc.|Sutro Biopharma, Inc. (STRO) - Prakiraan pendapatan perusahaan|MiNK Therapeutics, Inc. - Pendapatan mangsa ngarep perusahaan|HOWL (Werewolf) - Prakiraan volume dodolan|Prakiraan volume dodolan immixbio.com|Volume dodolan mangsa ngarep perusahaan CUE (Cue Biopharma Inc.)|PDSB: Pendapatan sing dikarepake perusahaan|Sonnet BioTherapeutics Holdings - Volume dodolan mangsa ngarep perusahaan|MAIABiotech.com (MAIA) - Volume dodolan sing dikarepake perusahaan|LIMN - Prakiraan pendapatan perusahaan|LVTX: Prakiraan pendapatan perusahaan|NXTC: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Leap Therapeutics Inc (LPTX)|Volume dodolan mangsa ngarep perusahaan INTS|Prakiraan pendapatan perusahaan SNSE (senseibio.com)|Prakiraan pendapatan perusahaan Theriva Biologics (TOVX)|Prakiraan volume pendapatan perusahaan GRTS|Kineta Bio - Volume dodolan mangsa ngarep perusahaan|NEXI - Volume dodolan mangsa ngarep perusahaan|TSBX: Volume dodolan mangsa ngarep perusahaan|VCNX (Vaccinex, Inc.) - Prakiraan pendapatan perusahaan|Harpoon Tx (HARP) - Prakiraan pendapatan perusahaan